Analystreport

Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating.

Adamas Pharmaceuticals, Inc.  (ADMS) 
Last adamas pharmaceuticals, inc. earnings: 2/25 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamaspharma.com/investors